Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;33(12):14051-14066.
doi: 10.1096/fj.201900396RR. Epub 2019 Oct 29.

Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer

Fatima Mohsen Mroueh  1 , Mohamed Noureldein  1 , Youssef H Zeidan  1   2 , Suzan Boutary  1 , Sara Abou Merhi Irani  1 , Stéphanie Eid  1 , Mary Haddad  1 , Rasha Barakat  1 , Frederic Harb  3 , Joseph Costantine  4 , Rouwaida Kanj  4 , Erik-Andre Sauleau  5 , Allal Ouhtit  6 , Sami T Azar  7   8 , Ali H Eid  9   6 , Assaad A Eid  1   8
Affiliations

Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer

Fatima Mohsen Mroueh et al. FASEB J. 2019 Dec.

Abstract

Cancer was recently annexed to diabetic complications. Furthermore, recent studies suggest that cancer can increase the risk of diabetes. Consequently, diabetes and cancer share many risk factors, but the cellular and molecular pathways correlating diabetes and colon and rectal cancer (CRC) remain far from understood. In this study, we assess the effect of hyperglycemia on cancer cell aggressiveness in human colon epithelial adenocarcinoma cells in vitro and in an experimental animal model of CRC. Our results show that Nox (NADPH oxidase enzyme) 4-induced reactive oxygen species (ROS) production is deregulated in both diabetes and CRC. This is paralleled by inactivation of the AMPK and activation of the mammalian target of rapamycin (mTOR) C1 signaling pathways, resulting in 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) accumulation, induction of DNA damage, and exacerbation of cancer cell aggressiveness, thus contributing to the genomic instability and predisposition to increased tumorigenesis in the diabetic milieu. Pharmacologic activation of AMPK, inhibition of mTORC1, or blockade of Nox4 reduce ROS production, restore the homeostatic signaling of 8-oxoguanine DNA glycosylase/8-oxodG, and lessen the progression of CRC malignancy in a diabetic milieu. Taken together, our results identify the AMPK/mTORC1/Nox4 signaling axis as a molecular switch correlating diabetes and CRC. Modulating this pathway may be a strategic target of therapeutic potential aimed at reversing or slowing the progression of CRC in patients with or without diabetes.-Mroueh, F. M., Noureldein, M., Zeidan, Y. H., Boutary, S., Irani, S. A. M., Eid, S., Haddad, M., Barakat, R., Harb, F., Costantine, J., Kanj, R., Sauleau, E.-A., Ouhtit, A., Azar, S. T., Eid, A. H., Eid, A. A. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.

Keywords: DNA damage; NADPH oxidases; colorectal cancer; mTORC1.

PubMed Disclaimer

References

REFERENCES

    1. Limburg, P. J., Vierkant, R. A., Fredericksen, Z. S., Leibson, C. L., Rizza, R. A., Gupta, A. K., Ahlquist, D. A., Melton L. J. III, Sellers, T. A., and Cerhan, J. R. (2006) Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am. J. Gastroenterol. 101, 1872-1879
    1. Oh, S.-W., Kim, Y.-H., Choi, Y. S., Chang, D. K., Son, H. J., Rhee, P.-L., Kim, J. J., Rhee, J. C., Yun, S. H., Lee, W. Y., Chun, H. K., Kim, D. H., and Shim, S. G. (2008) The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer. Dis. Colon Rectum 51, 56-61
    1. Ren, X., Zhang, X., Zhang, X., Gu, W., Chen, K., Le, Y., Lai, M., and Zhu, Y. (2009) Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China. Public Health 123, 540-544
    1. Elwing, J. E., Gao, F., Davidson, N. O., and Early, D. S. (2006) Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am. J. Gastroenterol. 101, 1866-1871
    1. Yang, Y. X., Hennessy, S., and Lewis, J. D. (2004) Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127, 1044-1050

Publication types

MeSH terms

LinkOut - more resources